OrthogenRx
www.orthogenrx.comOrthogenRx, Inc., now An Avanos Company, is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA). Headquartered in Doylestown, PA, we are an early stage private medical device company. Our first product, GenVisc® 850 (sodium hyaluronate), is the only five injection hyaluronic acid product produced from non-avian source material. TriVisc is our 3 injection hyaluronic acid offering.
Read moreOrthogenRx, Inc., now An Avanos Company, is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA). Headquartered in Doylestown, PA, we are an early stage private medical device company. Our first product, GenVisc® 850 (sodium hyaluronate), is the only five injection hyaluronic acid product produced from non-avian source material. TriVisc is our 3 injection hyaluronic acid offering.
Read moreCountry
State
Pennsylvania
Industry
Employees
11-50
Founded
2012
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Managed Markets
Email ****** @****.comPhone (***) ****-****Senior Vice President , Operations and Compliance
Email ****** @****.comPhone (***) ****-****Director Quality and Alliances
Email ****** @****.comPhone (***) ****-****Director of Sales Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(26)